GMED
Globus Medical, Inc.
NYSE · Healthcare · Medical - Devices · US
$75.65
−1.38%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$76.12
From 52W high−21.87%
Volume1.26M
Market cap$10.16B
P/E (TTM)19.1x
P/S (TTM)3.2x
Div yield—
Key dataOct 19, 2026
Open
$76.12
From 52W high
−21.87%
Volume
1.26M
Market cap
$10.16B
ValuationView details →
P/E (Fwd)
14.4x
EV/EBITDA
10.2x
P/E (TTM)
19.1x
RSI (14)
48.7
MomentumView details →
1D Return
−1.38%
YTD Return
−13.05%
SummaryUpdated Jun 1, 2026
Globus Medical, Inc. (NYSE:GMED) is a medical device company founded in 2003 and headquartered in Audubon, Pennsylvania. The company went public in 2012 and has grown through both organic expansion and strategic acquisitions to become a major player in the musculoskeletal medical device market. In September 2023, Globus completed a transformative merger with NuVasive, significantly expanding its product portfolio and global reach. The company has evolved from a spine-focused specialist into a comprehensive musculoskeletal solutions provider, offering products for spine, trauma, orthopedics, and enabling technologies including robotic surgical systems.
Similar companies
Latest newsMore news →
Globus Medical announced that it will showcase its SCRIPT patient-specific implants and new XLIF prone procedural solution at the 41st Annual North American Spine Society Meeting in San Antonio from October 14 to 17, 2026.6d agoGlobus Medical announced that it will release financial results for the third quarter ended September 30, 2026, after market close on November 5, 2026.7d ago